Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Significance of Leaders for Sustained Use of Evidence-Based Practices: A Qualitative Focus-Group Study with Mental Health Practitioners.

Egeland KM, Hauge MI, Ruud T, Ogden T, Heiervang KS.

Community Ment Health J. 2019 Jun 12. doi: 10.1007/s10597-019-00430-8. [Epub ahead of print]

PMID:
31190179
2.

Fast Translation within the First 45 Codons Decreases mRNA Stability and Increases Premature Transcription Termination in E. coli.

Pedersen S, Terkelsen TB, Eriksen M, Hauge MK, Lund CC, Sneppen K, Mitarai N.

J Mol Biol. 2019 Mar 15;431(6):1088-1097. doi: 10.1016/j.jmb.2019.01.026. Epub 2019 Jan 25.

PMID:
30690030
3.

Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.

Ersbøll AS, Bojer AS, Hauge MG, Johansen M, Damm P, Gustafsson F, Vejlstrup NG.

J Am Heart Assoc. 2018 Oct 16;7(20):e008991. doi: 10.1161/JAHA.118.008991.

4.

Rehabilitation for patients with rheumatic diseases: Patient experiences of a structured goal planning and tailored follow-up programme.

Dager TN, Kjeken I, Berdal G, Sand-Svartrud AL, Bø I, Dingsør A, Eppeland SG, Hagfors J, Hamnes B, Nielsen M, Slungaard B, Wigers SH, Hauge MI.

SAGE Open Med. 2017 Nov 10;5:2050312117739786. doi: 10.1177/2050312117739786. eCollection 2017.

5.

Single-molecule analysis of ligand efficacy in β2AR-G-protein activation.

Gregorio GG, Masureel M, Hilger D, Terry DS, Juette M, Zhao H, Zhou Z, Perez-Aguilar JM, Hauge M, Mathiasen S, Javitch JA, Weinstein H, Kobilka BK, Blanchard SC.

Nature. 2017 Jul 6;547(7661):68-73. doi: 10.1038/nature22354. Epub 2017 Jun 7.

6.

Gq and Gs signaling acting in synergy to control GLP-1 secretion.

Hauge M, Ekberg JP, Engelstoft MS, Timshel P, Madsen AN, Schwartz TW.

Mol Cell Endocrinol. 2017 Jul 5;449:64-73. doi: 10.1016/j.mce.2016.11.024. Epub 2016 Nov 28.

PMID:
27908836
7.

GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40).

Ekberg JH, Hauge M, Kristensen LV, Madsen AN, Engelstoft MS, Husted AS, Sichlau R, Egerod KL, Timshel P, Kowalski TJ, Gribble FM, Reiman F, Hansen HS, Howard AD, Holst B, Schwartz TW.

Endocrinology. 2016 Dec;157(12):4561-4569. Epub 2016 Oct 25.

PMID:
27779915
8.

Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.

Hassing HA, Fares S, Larsen O, Pad H, Hauge M, Jones RM, Schwartz TW, Hansen HS, Rosenkilde MM.

Biochem Pharmacol. 2016 Nov 1;119:66-75. doi: 10.1016/j.bcp.2016.08.018. Epub 2016 Aug 26.

9.

Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish population.

Vestmar MA, Andersson EA, Christensen CR, Hauge M, Glümer C, Linneberg A, Witte DR, Jørgensen ME, Christensen C, Brandslund I, Lauritzen T, Pedersen O, Holst B, Grarup N, Schwartz TW, Hansen T.

J Med Genet. 2016 Sep;53(9):616-23. doi: 10.1136/jmedgenet-2015-103728. Epub 2016 Apr 11.

PMID:
27068006
10.

Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening.

Norn C, Hauge M, Engelstoft MS, Kim SH, Lehmann J, Jones RM, Schwartz TW, Frimurer TM.

Structure. 2015 Dec 1;23(12):2377-2386. doi: 10.1016/j.str.2015.09.014. Epub 2015 Oct 29.

11.

Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?

Hauge M, Bruserud Ø, Hatfield KJ.

Eur J Haematol. 2016 Mar;96(3):211-21. doi: 10.1111/ejh.12690. Epub 2015 Nov 26. Review.

PMID:
26465810
12.

Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.

Reikvam H, Hauge M, Brenner AK, Hatfield KJ, Bruserud Ø.

Expert Rev Hematol. 2015 Jun;8(3):299-313. doi: 10.1586/17474086.2015.1032935. Epub 2015 Apr 3. Review.

PMID:
25835070
13.

GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo.

Hauge M, Vestmar MA, Husted AS, Ekberg JP, Wright MJ, Di Salvo J, Weinglass AB, Engelstoft MS, Madsen AN, Lückmann M, Miller MW, Trujillo ME, Frimurer TM, Holst B, Howard AD, Schwartz TW.

Mol Metab. 2014 Oct 24;4(1):3-14. doi: 10.1016/j.molmet.2014.10.002. eCollection 2015 Jan.

14.

STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.

Bruserud Ø, Nepstad I, Hauge M, Hatfield KJ, Reikvam H.

Expert Rev Hematol. 2015 Feb;8(1):29-41. doi: 10.1586/17474086.2015.971005. Epub 2014 Nov 6. Review.

PMID:
25374305
15.

Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.

Engelstoft MS, Norn C, Hauge M, Holliday ND, Elster L, Lehmann J, Jones RM, Frimurer TM, Schwartz TW.

Br J Pharmacol. 2014 Dec;171(24):5774-89. doi: 10.1111/bph.12877.

16.

Carbon monoxide may be an important molecule in migraine and other headaches.

Arngrim N, Schytz HW, Hauge MK, Ashina M, Olesen J.

Cephalalgia. 2014 Dec;34(14):1169-80. doi: 10.1177/0333102414534085. Epub 2014 May 9. Review.

PMID:
24816616
17.

"It is about taking grips and not let myself be ravaged by my body": a qualitative study of outcomes from in-patient multidisciplinary rehabilitation for patients with chronic rheumatic diseases.

Dager TN, Kjeken I, Fjerstad E, Hauge MI.

Disabil Rehabil. 2012;34(11):910-6. doi: 10.3109/09638288.2011.626485. Epub 2011 Nov 8.

PMID:
22066740
18.

'I have come here to learn how to cope with my illness, not to be cured': a qualitative study of patient expectations prior to a one-week self-management programme.

Hamnes B, Hauge MI, Kjeken I, Hagen KB.

Musculoskeletal Care. 2011 Dec;9(4):200-10. doi: 10.1002/msc.212. Epub 2011 Jul 20.

PMID:
21774066
19.

Late specialization: the key to success in centimeters, grams, or seconds (cgs) sports.

Moesch K, Elbe AM, Hauge ML, Wikman JM.

Scand J Med Sci Sports. 2011 Dec;21(6):e282-90. doi: 10.1111/j.1600-0838.2010.01280.x. Epub 2011 Mar 15.

PMID:
21401722
20.

"I am not only a disease, I am so much more". Patients with rheumatic diseases' experiences of an emotion-focused group intervention.

Zangi HA, Hauge MI, Steen E, Finset A, Hagen KB.

Patient Educ Couns. 2011 Dec;85(3):419-24. doi: 10.1016/j.pec.2010.12.032. Epub 2011 Feb 5.

PMID:
21300517
21.

Rheumatic diseases and sexuality: Disease impact and self-management strategies.

Helland Y, Kjeken I, Steen E, Kvien TK, Hauge MI, Dagfinrud H.

Arthritis Care Res (Hoboken). 2011 May;63(5):743-50. doi: 10.1002/acr.20424.

22.

Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).

Jatoi A, Dakhil SR, Foster NR, Ma C, Rowland KM Jr, Moore DF Jr, Jaslowski AJ, Thomas SP, Hauge MD, Flynn PJ, Stella PJ, Alberts SR.

J Thorac Oncol. 2008 May;3(5):516-20. doi: 10.1097/JTO.0b013e31816de276.

23.

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, Wos EJ, Moore DF, Kugler JW, Windschitl HE, Graham DL, Bernath AM Jr, Fitch TR, Soori GS, Jett JR, Adjei AA, Perez EA.

Lung Cancer. 2008 May;60(2):200-7. Epub 2007 Nov 28.

PMID:
18045731
24.

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

Haddock MG, Swaminathan R, Foster NR, Hauge MD, Martenson JA, Camoriano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DF Jr, Alberts SR.

J Clin Oncol. 2007 Jun 20;25(18):2567-72.

PMID:
17577035
25.

Feeding, artificial sucking habits, and malocclusions in 3-year-old girls in different regions of the world.

Caglar E, Larsson E, Andersson EM, Hauge MS, Ogaard B, Bishara S, Warren J, Noda T, Dolci GS.

J Dent Child (Chic). 2005 Jan-Apr;72(1):25-30.

PMID:
16119072
26.

Mutational effects on conformational changes of the dephospho- and phospho-forms of the Na+,K+-ATPase.

Toustrup-Jensen M, Hauge M, Vilsen B.

Biochemistry. 2001 May 8;40(18):5521-32.

PMID:
11331017
27.

Investigation of the translation-initiation factor IF2 gene, infB, as a tool to study the population structure of Streptococcus agalactiae.

Hedegaard J, Hauge M, Fage-Larsen J, Mortensen KK, Kilian M, Sperling-Petersen HU, Poulsen K.

Microbiology. 2000 Jul;146 ( Pt 7):1661-70.

PMID:
10878130
29.

A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence for recombination within and between species.

Poulsen K, Reinholdt J, Jespersgaard C, Boye K, Brown TA, Hauge M, Kilian M.

Infect Immun. 1998 Jan;66(1):181-90.

30.

Side effects associated with pneumococcal vaccination.

Nichol KL, MacDonald R, Hauge M.

Am J Infect Control. 1997 Jun;25(3):223-8.

PMID:
9202818
31.

Influenza vaccination of healthcare workers.

Nichol KL, Hauge M.

Infect Control Hosp Epidemiol. 1997 Mar;18(3):189-94.

PMID:
9090547
32.

Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.

Nichol KL, Mac Donald R, Hauge M.

J Gen Intern Med. 1996 Nov;11(11):673-7.

PMID:
9120653
33.

Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial.

Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M.

Arch Intern Med. 1996 Jul 22;156(14):1546-50.

PMID:
8687262
35.

The effectiveness of vaccination against influenza in healthy, working adults.

Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M.

N Engl J Med. 1995 Oct 5;333(14):889-93.

36.

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer.

Hauge MD, Long HJ, Hartmann LC, Edmonson JH, Webb MJ, Su J.

Invest New Drugs. 1992 Nov;10(4):299-301.

PMID:
1487403
37.

[Help after personal injury--how do you cope with it?].

Hauge MT, Biørn-Hansen J.

Fag Tidsskr Sykepleien. 1992 Jun 15;80(3):2-5, 13. Norwegian. No abstract available.

PMID:
1497974
38.

Phase II evaluation of menogaril in patients with advanced hypernephroma.

Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG.

Invest New Drugs. 1991 Aug;9(3):261-2.

PMID:
1838363
39.

An epidemiological study of congenital anorectal malformations: 15 Danish birth cohorts followed for 7 years.

Christensen K, Madsen CM, Hauge M, Kock K.

Paediatr Perinat Epidemiol. 1990 Jul;4(3):269-75.

PMID:
2374746
40.

Osteogenesis imperfecta: a genetic, radiological, and epidemiological study.

Andersen PE Jr, Hauge M.

Clin Genet. 1989 Oct;36(4):250-5.

PMID:
2805382
41.
42.

Evaluation of zygosity diagnosis in twin pairs below age seven by means of a mailed questionnaire.

Bønnelykke B, Hauge M, Holm N, Kristoffersen K, Gurtler H.

Acta Genet Med Gemellol (Roma). 1989;38(3-4):305-13.

PMID:
2698574
43.

Cystic fibrosis in Denmark 1945 to 1985. An analysis of incidence, mortality and influence of centralized treatment on survival.

Nielsen OH, Thomsen BL, Green A, Andersen PK, Hauge M, Schiøtz PO.

Acta Paediatr Scand. 1988 Nov;77(6):836-41.

PMID:
3264656
44.

Insufficiency fractures of the pelvis that simulate metastatic disease.

Hauge MD, Cooper KL, Litin SC.

Mayo Clin Proc. 1988 Aug;63(8):807-12.

PMID:
3398597
45.

Dyssegmental dysplasia in siblings: prenatal ultrasonic diagnosis.

Andersen PE Jr, Hauge M, Bang J.

Skeletal Radiol. 1988;17(1):29-31.

PMID:
3282308
46.

Prevalence of fasting hyperglycemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide: Fredericia survey of subjects 60-74 yr old.

Damsgaard EM, Faber OK, Frøland A, Green A, Hauge M, Holm NV, Iversen S.

Diabetes Care. 1987 Jan-Feb;10(1):26-32.

PMID:
3552511
47.

A cohort study of neural tube defects (NTD) in Denmark covering the first seven years of life.

Haase J, Green A, Hauge M, Holm NV, Mathiasen H.

Childs Nerv Syst. 1987;3(2):117-20.

PMID:
3304623
48.

[Osteogenesis imperfecta in Funen County. A clinical epidemiologic study].

Andersen PE Jr, Hauge M, Justesen P, Høst A.

Ugeskr Laeger. 1986 Oct 13;148(42):2685-7. Danish. No abstract available.

PMID:
3787774
49.

Facial clefts in sibs and children of epileptic patients.

Friis ML, Holm NV, Sindrup EH, Fogh-Andersen P, Hauge M.

Neurology. 1986 Mar;36(3):346-50.

PMID:
3951701
50.

The incidence and prevalence of familial polyposis coli in Denmark.

Bülow S, Holm NV, Hauge M.

Scand J Soc Med. 1986;14(2):67-74.

PMID:
3704586

Supplemental Content

Support Center